Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Photochemotherapy Induces Interferon Type III Expression via STING Pathway

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Human P2X7 receptor causes cycle arrest in RPMI-8226 myeloma cells to alter the interaction with osteoblasts and osteoclasts

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Crosstalk of Hedgehog and mTORC1 Pathways

    Research output: Contribution to journalReviewResearchpeer-review

  4. T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road

    Research output: Contribution to journalReviewResearchpeer-review

  5. Key Components of Human Myofibre Denervation and Neuromuscular Junction Stability are Modulated by Age and Exercise

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Quality of Information in YouTube Videos on Erectile Dysfunction

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Standardized reporting for sexual function following prostate cancer treatment

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Consulting "Dr Google" for sexual dysfunction: a contemporary worldwide trend analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Impact of Testicular Torsion on Testicular Function

    Research output: Contribution to journalReviewResearchpeer-review

  • Marianne Trier Bjerre
  • Maibritt Nørgaard
  • Ole Halfdan Larsen
  • Sarah Østrup Jensen
  • Siri H Strand
  • Peter Østergren
  • Mikkel Fode
  • Jacob Fredsøe
  • Benedicte Parm Ulhøi
  • Martin Mørck Mortensen
  • Jørgen Bjerggaard Jensen
  • Michael Borre
  • Karina D Sørensen
View graph of relations

Novel and minimally-invasive prostate cancer (PCa)-specific biomarkers are needed to improve diagnosis and risk stratification. Here, we investigated the biomarker potential in localized and de novo metastatic PCa (mPCa) of methylated circulating tumor DNA (ctDNA) in plasma. Using the Marmal-aid database and in-house datasets, we identified three top candidates specifically hypermethylated in PCa tissue: DOCK2,HAPLN3, and FBXO30 (specificity/sensitivity: 80%-100%/75-94%). These candidates were further analyzed in plasma samples from 36 healthy controls, 61 benign prostatic hyperplasia (BPH), 102 localized PCa, and 65 de novo mPCa patients using methylation-specific droplet digital PCR. Methylated ctDNA for DOCK2/HAPLN3/FBXO30 was generally not detected in healthy controls, BPH patients, nor in patients with localized PCa despite a positive signal in 98%-100% of matched radical prostatectomy tissue samples. However, ctDNA methylation of DOCK2,HAPLN3, and/or FBXO30 was detected in 61.5% (40/65) of de novo mPCa patients and markedly increased in high- compared to low-volume mPCa (89.3% (25/28) vs. 32.1% (10/31), p < 0.001). Moreover, detection of methylated ctDNA was associated with significantly shorter time to progression to metastatic castration resistant PCa, independent of tumor-volume. These results indicate that methylated ctDNA (DOCK2/HAPLN3/FBXO30) may be potentially useful for identification of hormone-naïve mPCa patients who could benefit from intensified treatment.

Original languageEnglish
Article number1362
JournalCells
Volume9
Issue number6
ISSN2073-4409
DOIs
Publication statusPublished - 31 May 2020

ID: 60069184